Home > Insider Trading > Filing (0001123292-15-001188)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1437786	Immune Design Corp.	IMDZ	Pharmaceutical Preparations (2834)	262007174

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1605922	Wayne Gombotz	C/O Immune Design Corp. 1616 Eastlake Ave. E., Suite 310 Seattle WA 98102	Chief Development Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-09-14	5,000	$1.31	5,034	No	4	M	Direct
Common Stock	Disposition	2015-09-14	5,000	$16.19	34	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2015-09-14	5,000	$0.00	5,000	$1.31

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
53,715		2021-12-08	No	4	M	Direct

Footnotes

Reflects the acquisition of 34 shares on June 30, 2015 pursuant to the Immune Design Corp. 2014 Employee Stock Purchase Plan.
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.01 to $16.62, inclusive. The reporting person undertakes to provide to Immune Design Corp. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
One quarter of the shares underlying the option vested on December 1, 2012, and the remainder of the shares underlying the option vest at a rate of 1/36th per month thereafter.